These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16990202)

  • 1. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.
    Oostenbrug LE; Dijkstra G; Nolte IM; van Dullemen HM; Oosterom E; Faber KN; de Jong DJ; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL
    Scand J Gastroenterol; 2006 Oct; 41(10):1174-82. PubMed ID: 16990202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.
    Ho GT; Soranzo N; Nimmo ER; Tenesa A; Goldstein DB; Satsangi J
    Hum Mol Genet; 2006 Mar; 15(5):797-805. PubMed ID: 16434479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.
    Oostenbrug LE; Nolte IM; Oosterom E; van der Steege G; te Meerman GJ; van Dullemen HM; Drenth JP; de Jong DJ; van der Linde K; Jansen PL; Kleibeuker JH
    Dig Liver Dis; 2006 Nov; 38(11):834-45. PubMed ID: 16920047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
    Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
    Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.
    Potocnik U; Ferkolj I; Glavac D; Dean M
    Genes Immun; 2004 Nov; 5(7):530-9. PubMed ID: 15505619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
    Cucchiara S; Latiano A; Palmieri O; Canani RB; D'Incà R; Guariso G; Vieni G; De Venuto D; Riegler G; De'Angelis GL; Guagnozzi D; Bascietto C; Miele E; Valvano MR; Bossa F; Annese V;
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):171-9. PubMed ID: 17255827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Bossa F; Latiano T; Devoto M; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1129-38. PubMed ID: 16305727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
    Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J
    Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
    Taheri M; Mahjoubi F; Omranipour R
    Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M; Karban A; Nesher S; Weiss B; Shamir R; Eliakim R
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
    Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.